|
|
Hokkaido University Collection of Scholarly and Academic Papers >
Showing results 1 to 5 of 5
| Type | Author(s) | Title | Other Titles | Citation | Citation(alt) | Issue Date | | article (author version) | Hosoda, Mitsuchika; Yamamoto, Mitsugu; Nakano, Kiichiroh; Hatanaka, Kanako C.; Takakuwa, Emi; Hatanaka, Yutaka; Matsuno, Yoshihiro; Yamashita, Hiroko | Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer | - | Breast Cancer Research and Treatment | - | Apr-2014 |
| article (author version) | Ishida, Naoko; Araki, Kazuhiro; Sakai, Takehiko; Kobayashi, Kokoro; Kobayashi, Takayuki; Fukada, Ippei; Hosoda, Mitsuchika; Yamamoto, Mitsugu; Ichinokawa, Kazuomi; Takahashi, Shunji; Iwase, Takuji; Ito, Yoshinori; Yamashita, Hiroko | Fulvestrant 500 mg in postmenopausal patients with metastatic breast cancer : the initial clinical experience | - | Breast cancer | - | Jul-2016 |
| article | Yamamoto, Mitsugu; Hosoda, Mitsuchika; Nakano, Kiichiroh; Jia, Shusheng; Hatanaka, Kanako C.; Takakuwa, Emi; Hatanaka, Yutaka; Matsuno, Yoshihiro; Yamashita, Hiroko | p53 accumulation is a strong predictor of recurrence in estrogen receptor-positive breast cancer patients treated with aromatase inhibitors | - | Cancer science | - | Jan-2014 |
| article (author version) | Yoshioka, Tatsuya; Hosoda, Mitsuchika; Yamamoto, Mitsugu; Taguchi, Kazunori; Hatanaka, Kanako C.; Takakuwa, Emi; Hatanaka, Yutaka; Matsuno, Yoshihiro; Yamashita, Hiroko | Prognostic significance of pathologic complete response and Ki67 expression after neoadjuvant chemotherapy in breast cancer | - | Breast Cancer | - | Mar-2015 |
| article | Tomioka, Nobumoto; Hatanaka, Kanako C.; Okuyama, Dai; Watanabe, Ken-ichi; Yamamoto, Mitsugu; Maeda, Hideki; Tachikawa, Hanae; Kuwahara, Sayuri; Shimizu, Ai; Suzuki, Hiroaki; Hatanaka, Yutaka; Takahashi, Masato | Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region | - | Breast cancer | - | 1-May-2023 |
Showing results 1 to 5 of 5
|
